Salvianolic acid b protects SH-SY5Y neuroblastoma cells from1-methyl-4- phenylpyridinium-induced apoptosis

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 8, 2010, Pages 1337-1342

  Zeng, Guang ^a   Tang, Tao ^a   Wu, Han Jun ^a   You, Wan Hui ^a   Luo, Jie Kun ^a   Lin, Yuan ^a   Liang, Qing Hua ^a   Li, Xing Qun ^a   Huang, Xi ^a   Yang, Qi Dong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

1 methyl 4 phenylpyridinium; Antioxidation; Neuroprotection; Parkinson's disease; Salvianolic acid B; SH SY5Y

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; CYTOCHROME C; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SALVIANOLIC ACID B;

APOPTOSIS; ARTICLE; CELL LOSS; CELL PROTECTION; CELL STRAIN; CELL STRAIN SH SY5Y; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOTYPE; PROTEIN EXPRESSION;

1-METHYL-4-PHENYLPYRIDINIUM; ANTIPARKINSON AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOFURANS; BIOLOGICAL ASSAY; CASPASE 3; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MOLECULAR STRUCTURE; NEUROBLASTOMA; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-BCL-6; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77956132036     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1337     Document Type: Article

References (35)

1. Alves G., Forsaa E. B., Pedersen K. F., Dreetz G. M., Larsen J. P., J. Neurol., 255 (Suppl. 5), 18-32 (2008).
2. Mattson M. P., Nat. Rev. Mol. Cell. Biol., 1, 120-129 (2000).
3. Halliwell B., Drugs Aging, 18, 685-716 (2001).
4. Pietarinen P., Raivio K., Devlin R. B., Crapo J. D., Chang L. Y., KinnulaV. L., Am. J. Respir. Cell. Mol. Biol., 13, 434-441 (1995).
5. Przedborski S., Jackson-Lewis V., Mov. Disord., 13 (Suppl. 1), 35-38 (1998).
6. Singer T. P., Ramsay R. R., FEBS Lett., 274, 1-8 (1990).
7. Seaton T. A., Cooper J. M., Schapira A. H., Brain Res., 809, 12-17 (1998).
8. Cassarino D. S., Parks J. K., Parker W. D. Jr., Bennett J. P. Jr., Biochim. Biophys. Acta, 1453, 49-62 (1999).
9. Di M. D., Sandy M. S., Ekstrom G., Smith M. T., Biochem. Biophys. Res. Commun., 137, 303-309 (1986).
10. Blum D., Torch S., Lambeng N., Nissou M., Benabid A. L., Sadoul R., Verna J. M., Prog. Neurobiol., 65, 135-172 (2001).
11. Crompton M., Curr. Opin. Cell. Biol., 12, 414-419 (2000).
12. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., Wang X., Science, 275, 1129-1132 (1997).
13. Zhou L., Zuo Z., Chow M. S., J. Clin. Pharmacol., 45, 1345-1359 (2005).
14. Chen Y. H., Du G. H., Zhang J. T., Acta Pharmacol. Sin., 21, 463-466 (2000).
15. Kim S. Y., Kim M. Y., Mo J. S., Park J. W., Park H. S., Neurosci. Lett., 413, 132-136 (2007).
16. Wang X. J., Xu J. X., Neurosci. Res., 51, 129-138 (2005).
17. Kitamura Y., Kosaka T., Kakimura J. I., Matsuoka Y., Kohno Y., Nomura Y., Taniguchi T., Mol. Pharmacol., 54, 1046-1054 (1998).
18. Jung T. W., Lee J. Y., Shim W. S., Kang E. S., Kim S. K., Ahn C. W., Lee H. C., Cha B. S., J. Neurol. Sci., 253, 53-60 (2007).
19. Jung T. W., Lee J. Y., Shim W. S., Kang E. S., Kim S. K., Ahn C. W., Lee H. C., Cha B. S., Biochem. Biophys. Res. Commun., 343, 564-570 (2006).
20. Lu J., Park C. S., Lee S. K., Shin D. W., Kang J. H., Neurosci. Lett., 407, 240-243 (2006).
21. Lotharius J., O'Malley K. L., J. Biol. Chem., 275, 38581-38588 (2000).
22. Wang X., Genes Dev., 15, 2922-2923 (2001).
23. Grutter M. G., Curr. Opin. Struct. Biol., 10, 649-655 (2000).
24. Gross A., McDonnell J. M., Korsmeyer S. J., Genes Dev., 13, 1899-1911 (1999).
25. McDonnell T. J., Beham A., Sarkiss M., Andersen M. M., Lo P., Experientia, 52, 1008-1017 (1996).
26. Miller T. M., Moulder K. L., Knudson C. M., Creedon D. J., Deshmukh M., Korsmeyer S. J., Johnson E. M. Jr., J. Cell. Biol., 139, 205-217 (1997).
27. Cory S., Adams J. M., Nat. Rev. Cancer, 2, 647-656 (2002).
28. Lin Y. L., Wu C. H., Luo M. H., Huang Y. J., Wang C. N., Shiao M. S., J. Ethnopharmacol., 105, 215-222 (2006).
29. Luo P., Tan Z., Zhang Z., Li H., Mo Z., Biol. Pharm. Bull., 31, 1381-1386 (2008).
30. Lay I. S., Hsieh C. C., Chiu J. H., Shiao M. S., Lui W. Y., Wu C. W., J. Surg. Res., 115, 279-285 (2003).
31. Zhao B. L., Jiang W., Zhao Y., Hou J. W., Xin W. J., Biochem. Mol. Biol. Int., 38, 1171-1182 (1996).
32. Liu C. S., Cheng Y., Hu J. F., Zhang W., Chen N. H., Zhang J. T., Acta Pharmacol. Sin., 27, 1137-1145 (2006).
33. Wu H. L., Li Y. H., Lin Y. H., Wang R., Li Y. B., Tie L., Cardiovasc. Res., 81, 148-158 (2009).
34. Tian L. L., Wang X. J., Sun Y. N., Li C. R., Xing Y. L., Zhao H. B., Int. J. Biochem. Cell. Biol., 40, 409-422 (2008).
35. Liu C. S., Chen N. H., Zhang J. T., Phytomedicine, 14, 492-497 (2007).